Medical and Diagnostics laboratories Email List | FountMedia

Digital Pathology Market Research Report, By Type (Human Pathology, Animal Pathology), By Product (Hardware, Software, Storage), By Application (Telemedicine, Drug Discovery, Disease Diagnosis, mhealth) and By End-user (Hospitals & Clinics, Research Centers & Academic Institutes, Diagnostic Centers) Global Forecast till 2027Digital Pathology Market HighlightsDigital Pathology or Computational Pathology leverages completely new perceptions through data analysis, enabling pathologists to consult on treatment options.

There have been several innovations and widespread adoption of digital pathology.

Hence, pathology centers across the globe are increasingly adopting digital pathology to increase diagnostic speeds and accuracy.

Additionally, the advanced medical services and the burgeoning healthcare sector worldwide are fostering the growth of the digital pathology market.

The demand for fast proceedings of treatments, with an accurate diagnosis, is rising, which results in the growth of the digital pathology market.The transition to cloud pathology is a prominent trend, observed during the analysis, which is expected to push up the growth in the market.

Technology experts think that machine learning and other sophisticated technologies could assist pathologists, making them more precise in their analysis.AI has the capacity of turning pathology into a digital zone.

The global home diagnostics market study presents an all in all compilation of the historical, current and future outlook of the market as well as the factors responsible for such a growth.

With SWOT analysis, the business study highlights the strengths, weaknesses, opportunities and threats of each home diagnostics market player in a comprehensive way.

Further, the home diagnostics market report emphasizes the adoption pattern of the home diagnostics across various industries.The home diagnostics market report highlights the following players:True Diagnostics Inc.Becton Dickinson & CompanyAssure Tech (Hangzhou) co. Ltd.ACON Laboratories Inc.OthersThe home diagnostics market report examines the operating pattern of each player – new product launches, partnerships, and acquisitions – has been examined in detail.FactMR, in its latest market study, opines that the home diagnostics market will grow at a healthy 3.5% value CAGR, surpassing US$ 6.3 million by 2026.

According to the report, sales will remain buoyant in developed regions, with North America and Europe collectively accounting for over 50% revenue share of the market.

The Fact.MR study remains bullish on the prospects of home diagnostics market players in developing countries, as growing focus on health & wellness, and emergence of many Asian countries as medical tourism hubs creates opportunities.Increasing preference for self-diagnosis continues to be a trigger for home diagnostics sales, whereas a combination of industry-specific and regulatory factors continue to influence the strategies of market players.

Governing bodies such as the U.S. Food and Drug Administration (FDA) and the European Commission regulate home diagnostics with stringent quality control regulations and labeling requirements.

Clinical Laboratory Services Market Research By Application (Hospital Laboratory, Independent Laboratory and Reference Laboratory), Type and Key Players, Forecast To 2023

Pune, India – July 18, 2019 —

MRFR forecasts that the global clinical laboratory services market to demonstrate a brilliant growth owing to surge in the number of clinical trials.

As per the MRFR report, between 2018 and 2023 the global Clinical Laboratory Services Market is envisaged to surpass a substantial valuation of USD 274,400 million.

On the basis of type, the market has been segmented into

The hematology segment can exhibit highest growth in the coming years owing to the increasing cases of leukaemia, urging intensive clinical activities for developing effective treatment.

A hematology test is a measurement of blood to help diagnose and monitor many conditions.

These include blood and bone marrow cells.

Rescue Lab performs routine hematology testing, limited coagulation, and various body fluid testing and analysis.

The testing utilizes the latest technologies to provide the most accurate results.

Complete blood counts (CBC) provides white blood cell results (white blood cell count, differential cell count and leukocyte morphology), red cell results (red cell count, hemoglobin concentration, hematocrit, red cell indices and red cell morphology), platelet results (platelet count, mean platelet volume and smear estimate.

The Hematology Laboratory also performed body fluid analysis including:Automated Urinalysis with the IRISRapid pregnancy screeningStool analyses for occult bloodJoint fluid analyses for crystal evaluation, cell counts, WBC differentialsCell counts and WBC differentials on CNS, pleural and ascetic fluidsHematology is the specialty responsible for the diagnosis and management of a wide range of benign and malignant disorders of the red and white blood cells, platelets and the coagulation system in adults and children.

Market OverviewThe Global Carcinoembryonic Antigen (CEA) Market is expected to grow at a high CAGR during the forecasting period (2020-2027).Carcinoembryonic antigen (CEA) is a glycoprotein normally found in embryonic entodermal epithelium.

Download free sample: https://www.datamintelligence.com/download-sample/carcinoembryonic-antigen-market Market DynamicsThe growth of the global carcinoembryonic antigen (CEA) market is driven by several factors such as, rising incidence rate for cancer, growing demand for minimally invasive diagnostics procedures, and increasing geriatric population.According to the WHO, cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018.

All these factors are expected to boost the market growth during the forecast period.The development of novel combination biomarkers and initiatives by the government concerning improved diagnostic rates are likely to open growth avenues for CEA market.

The advent of various tumor markers, which can be used along with CEA to monitor or diagnose colorectal cancer is predicted to influence the market growth positively.Carcinoembryonic antigen is the recurrent indicator in asymptomatic patients and presently the most cost-effective assessment for preclinical detection of illness.

The test is beneficial for the primary detection of liver metastasis in patients with diagnosed colorectal cancer.However, ineffective approach for cancer detection at initial stage and lack of awareness are restraining the carcinoembryonic antigen market growth.

Market Geographical AnalysisNorth America is dominating the global carcinoembryonic antigen (CEA) market accounting for largest market share in 2018, owing to the rising incidence of cancer in this region, growing awareness about detecting cancer at an early stage and advanced health care services for cancer therapeutics.

The global medical automation industry is expected to reach USD 79.4 billion by 2024, according to a new report by Grand View Research, Inc.

For example, the automation of tedious tasks such as sampling, monitoring of quality, quantity, packaging and labeling, and scanning of medicines and devices, have reduced human efforts and increased speed and accuracy, which has led to increased dependency on these automated systems.

Moreover, the growing global prevalence of chronic conditions such as diabetes, cancer, arthritis, and chronic obstructive pulmonary disease (COPD) is further pushing the demand for therapeutic, laboratory and pharmacy automated medication systems, which are faster and more productive.

The aforementioned factors are responsible for creating the need for automated medical equipments over the forecast period.

For instance, automation in the following pharmacy-based functions, medication dispensing, storage, and retrieval enables traceability and tracking, which in turn improves patient safety and reduces errors.

Furthermore, there is an increased focus on incorporating automation in hospitals due to the associated benefits, such as reduction of errors and operational costs; these factors altogether are expected to present this market with high growth opportunities in the near future.Further key findings from the study suggest:The therapeutic segment was observed to dominate in terms of revenue share in 2015owing to the high usage rate of automated devices in the non-surgical procedures, such as external defibrillators, an implantable cardioverter, and wearable/ implantable drug pumps On the other hand, the medical logistics and training segment is expected to grow at a lucrative CAGR of over 10.0%.

This report on the Global Clinical Reference Laboratory Services Market provides a global 360-degree perspective of the industry while taking into consideration historical data as well as providing accurate estimations of the future scope of the market.

This make it easier for the stakeholders of the report to utilize this information and incorporate changes in their business policies and be well informed about the market dynamics.

It also provides an insight into the competitive landscape of the market highlighting key competitors, major manufacturers dominating the Clinical Reference Laboratory Services Market, while also providing an analysis of the market share and revenue generation figures.Ask for report free sample with complete TOC and list of tables/figures @ https://www.datalibraryresearch.com/sample-request/clinical-reference-laboratory-market-2157Global Clinical Reference Laboratory Services Market Competitive Analysis:Sonic HealthCare Limited,Aurora Diagnostics,Unilabs,Quest Diagnostics,ARUP Laboratories,Clinical Reference Laboratories,SYNLAB International Gmbh,KingMed DiagnosticsDrivers & ConstraintsThe report largely stresses on the importance of market dynamics in understanding the Clinical Reference Laboratory Services Market industry.

Additionally, the report also calls out regions that have showed maximum growth in the past as well as regions that emerged as leaders of the market in historic years.

*All our reports are customizable as per customer requirementsThis study forecasts revenue and volume growth at global, regional, and country levels from 2016 to 2027.

Global Biosimilars market is distributed on the basis of below mentioned segments:Global Biosimilars market, By Segment 1:    Sub-Segment 1    Sub-Segment 2    Sub-Segment 3    OthersGlobal Biosimilars market, By Segment 2:    Sub-Segment 1    Sub-Segment 2    Sub-Segment 3    OthersGlobal Biosimilars market, By Segment 3:    Sub-Segment 1    Sub-Segment 2    Sub-Segment 3    OthersBrowse Complete Report @ https://www.datalibraryresearch.com/reports/clinical-reference-laboratory-market-2157About Data Library Research:Data Library Research is a market research company that helps to find its passion for helping brands grow, discover, and transform.